Seattle Genetics, Inc. Announces Corporate Name Change to Seagen Inc. - Seite 3

Nachrichtenquelle: Business Wire (engl.)
08.10.2020, 14:00  |  276   |  0   |   

Diesen Artikel teilen
Seite 3 von 3
Wertpapier


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Seattle Genetics, Inc. Announces Corporate Name Change to Seagen Inc. - Seite 3 Seagen Inc. is the new corporate name for Seattle Genetics, Inc. (Nasdaq:SGEN), a global biotechnology company dedicated to developing innovative cancer medicines that make a meaningful difference in people’s lives around the world. The evolution of …

Nachrichten des Autors

Titel
Nickelodeon Establishes Avatar Studios, Brand-New Content Division Devoted to Expanding the World of Avatar: The Last Airbender and The Legend of Korra
AWS Announces General Availability of Amazon Lookout for Vision
Innovative Industrial Properties Reports Fourth Quarter and Full-Year 2020 Results
American Water Reports 2020 Results
All Three Independent Proxy Advisory Firms – ISS, Glass Lewis and Egan-Jones – Recommend ...
Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for ...
ViacomCBS Unveils Comprehensive Streaming Strategy and Expansive Slate of Originals Headed to ...
Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for ...
Nutanix Reports Second Quarter Fiscal 2021 Financial Results
The New England Journal of Medicine Publishes Results from Pivotal Phase 2 KarMMa Study of ...
Titel
BevCanna Closes Transformative Acquisition of Naturo Group
Jumia Reports Fourth Quarter and Full Year 2020 Results
Palantir and 3M Expand Relationship to Build Dynamic Supply Chain
Europcar Mobility Group: Successful C. Eur 50 Million Share Capital Increase With Shareholders’ Preferential Subscription ...
Square, Inc. Announces Fourth Quarter and Full Year 2020 Results
EBIX ALERT– Shareholder Rights Firm Labaton Sucharow is Investigating EBIX INC. (NASDAQ: EBIX) for Potential Securities Violations and Breach of Fiduciary Duty
Nickelodeon Establishes Avatar Studios, Brand-New Content Division Devoted to Expanding the World of Avatar: The Last Airbender and The Legend of Korra
AMC Theatres' Statement on the Reopening of Movie Theatres in New York City
TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, ...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ebix, ...
Titel
EQ Health Acquisition Corp. Announces Pricing of Upsized $191.1 Million Initial Public Offering
VIQ Solutions Named to 2021 OTCQX Best 50
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of EHang Holdings Limited (EH) on Behalf of ...
BevCanna Completes Next Step in Transformative Acquisition of Naturo Group
Global cryptocurrency miner Argo Blockchain enters into LOI to Build 200 MW Mining Facility in ...
Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design
Launch of a capital increase with shareholders’ preferential subscription right of approximately ...
AMC Completes At the Market Equity Program
BevCanna Announces Receipt of Health Canada Standard Processing License
Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
Titel
WEX Merchant Partners Offer Fuel Discounts to Truckers
Dolores J. Ennico Nominated to Join RBC Bearings Board of Directors
Cypress Unveils IoT-AdvantEdge Solutions Providing Developers a Trusted Design Path to IoT Edge ...
Halo Labs President Katie Field to Present at the 2020 Virtual Benzinga Cannabis Capital Conference
Halo Announces Results of Annual General Meeting
Halo Provides Operational Update
Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic
Halo Enters Into Second Amended and Restated Convertible Promissory Note For Aggregate Principal ...
Wells Fargo Bank Decreases Prime Rate to 4.25 Percent
Halo Labs Provides Oregon Business Update

Nachrichten zu den Werten

ZeitTitel
24.02.21
Seagen to Present at the Cowen 41st Annual Healthcare Conference
20.02.21
Chartgalerie - Top / Flop Aktien Wochenrückblick Kalenderwoche 07/21
18.02.21
Seagen and Astellas Announce Submission of Two Supplemental Biologics License Applications to the U.S. FDA for PADCEV (enfortumab vedotin-ejfv) in Locally Advanced or Metastatic Urothelial Cancer
12.02.21
Seagen and Astellas Announce Presentation of Results from PADCEV (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced Urothelial Cancer Who Were Ineligible for Cisplatin Chemotherapy
12.02.21
Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer
12.02.21
European Commission Approves Seagen’s TUKYSA (tucatinib) for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer
11.02.21
Seagen Reports Fourth Quarter and Full Year 2020 Financial Results
10.02.21
Seagen and Genmab Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
30.01.21
Chartgalerie - Top / Flop Aktien Wochenrückblick Kalenderwoche 04/21